You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

symptomatic multiple myeloma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial (Linvoseltamab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Apr 12, 2023

Recurrent Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Laboratory Biomarker Analysis, Lenalidomide)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Myeloma Trial in France (18F-Fludarabine)

Not yet recruiting
  • Myeloma
  • Angers, France
  • +6 more
Dec 24, 2021

Multiple Myeloma Trial in Nantes ([68Ga]Ga-PentixaFor)

Recruiting
  • Multiple Myeloma
  • Nantes, France
    Nantes UH
Sep 24, 2021

People With Multiple Myeloma in Portugal

Recruiting
  • Relapse and/or Refractory Multiple Myeloma
    • Braga, Portugal
    • +7 more
    Jun 9, 2022

    Biology and Genetics of Smouldering Myeloma

    Recruiting
    • Smouldering Myeloma
    • +2 more
    • No intervention
    • London, United Kingdom
      University College London Hospitals
    Sep 15, 2021

    Bone Pain, Metastatic Malignant Tumor in the Bone, Plasma Cell Myeloma Trial in United States (Quality-of-Life Assessment,

    Recruiting
    • Bone Pain
    • +2 more
    • Quality-of-Life Assessment
    • +2 more
    • Duarte, California
    • +7 more
    Feb 25, 2022

    Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)

    Not yet recruiting
    • Multiple Myeloma
    • Miami, Florida
      University of Miami
    Oct 20, 2023

    Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • Myeloma-Associated Amyloidosis
    • Saint Louis, Missouri
      Washington University School of Medicine
    Apr 6, 2023

    Smoldering Multiple Myeloma Trial (Selinexor)

    Not yet recruiting
    • Smoldering Multiple Myeloma
    • (no location specified)
    Oct 27, 2022

    Multiple Myeloma Trial in Germany (Bendamustine, Bortezomib, Prednisone)

    Completed
    • Multiple Myeloma
    • Bendamustine, Bortezomib, Prednisone
    • Mannheim, Ba-Wü, Germany
    • +14 more
    Oct 14, 2020

    Project in First-degree Relatives of Myeloma Patient - The

    Recruiting
    • Multiple Myeloma
    • Monoclonal Gammopathy of Undetermined Significance
    • Sample of Blood
    • Shanghai, Shanghai, China
      Zhongshan Hospital，Fudan University
    Jul 31, 2023

    Biomarker for Infection Risk in CLL and MM

    Not yet recruiting
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Screening
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    May 3, 2023

    Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)

    Recruiting
    • Multiple Myeloma
    • APRIL-BAFF-Bicephali CAR-T cells
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Nov 14, 2023

    Developing Myeloma in a High-Risk Screened Population (PROMISE)

    Recruiting
    • Multiple Myeloma
    • Sample of Blood
    • Baltimore, Maryland
    • +2 more
    Mar 22, 2022

    Multiple Myeloma Trial run by the National Cancer Institute (NCI) (Dexamethasone, Carfilzomib, Daratumumab)

    Recruiting
    • Multiple Myeloma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma Trial in Boston (Elranatamab)

    Not yet recruiting
    • Refractory Multiple Myeloma
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Nov 17, 2023

    Multiple Myeloma Trial in Tucson (Immediate yoga intervention, Delayed yoga intervention)

    Not yet recruiting
    • Multiple Myeloma
    • Immediate yoga intervention
    • Delayed yoga intervention
    • Tucson, Arizona
      University of Arizona Cancer Center
    Sep 27, 2023

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

    Not yet recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • (no location specified)
    Oct 30, 2023

    Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)

    Recruiting
    • Plasma Cell Myeloma
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Multiple Myeloma Trial (AZD0305)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Oct 24, 2023

    Laboratory Biomarkers in Elderly Patients With Multiple Myeloma

    Recruiting
    • Plasma Cell Myeloma
    • Biospecimen Collection
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jun 26, 2023

    Multiple Myeloma Trial (Teclistamab, Tocilizumab)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Jul 24, 2023

    Multiple Myeloma, Relapsed Hematologic Malignancy Trial in Seattle (Digital Health Coaching Program, Fitbit)

    Recruiting
    • Multiple Myeloma
    • Relapsed Hematologic Malignancy
    • Digital Health Coaching Program
    • Fitbit
    • Seattle, Washington
      University of Washington
    Jul 13, 2023

    Clinical Pathways for Newly Diagnosed Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma
    • Multiple Myeloma Without Mention of Remission
    • Multiple Myeloma Pathway
    • +2 more
    • (no location specified)
    Nov 27, 2023